文献速递鼻科

糖皮质激素反应预测CRSwNP患者ESS后嗅觉结局

Response to Glucocorticosteroids Predicts Olfactory Outcome After ESS in Chronic Rhinosinusitis.
PubMed 文献 · Laryngoscope · 2019-08-02

这项前瞻性研究纳入52例慢性鼻窦炎伴鼻息肉(CRSwNP)患者,分为术前口服糖皮质激素组(n=21)和未用激素对照组(n=31),均接受内镜鼻窦手术(ESS)。结果显示激素后TDI评分改善者占57%,且激素后改善与术后3个月TDI显著相关(r=0.66,P=0.01);激素后嗅觉无改善者手术亦无获益,术后TDI在1个月达峰、3个月下降。

要点

  • 术前糖皮质激素后TDI改善可预测ESS后3个月嗅觉结局。
  • 激素后嗅觉无改善的CRSwNP患者未能从手术中获益。
  • ESS后嗅觉TDI在1个月达峰,约3个月后回落。

核心结论

  • 糖皮质激素改善CRSwNP患者嗅觉的程度与手术相当。
  • 激素相关的嗅觉变化可预测ESS术后嗅觉结局。
  • 术后嗅觉功能在1个月升高、3个月下降。

研究设计与样本

  • 前瞻性研究纳入52例CRSwNP患者(30男22女,平均年龄54±14岁)。
  • 对照组31例仅行ESS,治疗组21例术前口服糖皮质激素。
  • 采用扩展Sniffin' Sticks测试(TDI评分)及嗅觉自评,术前、激素后及术后2周、1个月、3个月评估。

主要发现

  • 激素后57%患者TDI评分显著改善,43%无变化。
  • 激素后TDI改善与术后3个月TDI显著相关(r=0.66,P=0.01)。
  • 激素后嗅觉未改善者手术亦无获益。
  • 术后TDI在1个月达最大值,约3个月后下降。

关键数值与推荐

  • TDI评分改善与术后3个月结局相关系数r=0.66,P=0.01。
  • 激素后TDI改善者占57%,无变化者占43%。
  • 证据等级:Level of Evidence 2(Laryngoscope, 130:1616-1621, 2020)。

临床怎么用

  • CRSwNP患者术前可考虑口服糖皮质激素以评估嗅觉反应。
  • 激素后嗅觉无改善者应审慎评估ESS对嗅觉的获益。
  • 术后嗅觉随访需关注1个月达峰后3个月回落趋势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Olfaction is frequently impaired in chronic rhinosinusitis with nasal polyps (CRSwNP) and often improves after endoscopic sinus surgery (ESS). Data about dynamics of olfactory changes after ESS are lacking, and little information is available concerning whether preoperatively administered glucocorticosteroids predict postoperative olfaction. Therefore, the aim of this study was to examine dynamics of olfaction after ESS in relation to the effect of preoperative administration of glucocorticosteroids in CRSwNP. METHODS: This prospective study included 52 CRSwNP patients (30 men, 22 women, mean age 54 ± 14 years) divided into a control group (n = 31) subjected to ESS without preoperative steroids and a treatment group (n = 21) receiving orally administered glucocorticosteroids preoperatively. Self-ratings of olfaction and olfactory testing using the extended Sniffin' Sticks test battery (threshold, discrimination and identification [TDI] score) were performed. Olfaction was measured preoperatively; after termination of glucocorticosteroid treatment (only treatment group); and 2 weeks, 1 month, and 3 months postoperatively. RESULTS: After glucocorticosteroids, TDI score significantly improved in 57% of patients, and olfactory function remained unchanged in 43%. In addition, improvement in TDI score after steroids and 3 months postoperatively were significantly correlated (r = 0.66, P = 0.01). Patients whose olfaction did not improve after glucocorticosteroids did not benefit from surgery. Regarding postoperative olfactory dynamics, TDI score reached its maximum 1 month postoperatively and decreased again approximately 3 months after surgery. CONCLUSION: Glucocorticosteroids improved olfaction in CRSwNP comparable to surgery. In addition, changes in relation to steroids predicted olfactory outcome postoperatively. Regarding the olfactory dynamics, it could be demonstrated that olfactory function increased 1 month after surgery and decreased 3 months postoperatively. LEVEL OF EVIDENCE: 2 Laryngoscope, 130:1616-1621, 2020.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Bogdanov V, Walliczek-Dworschak U, Whitcroft KL, et al. Response to Glucocorticosteroids Predicts Olfactory Outcome After ESS in Chronic Rhinosinusitis. Laryngoscope. 2019. PMID: 31373696. doi:10.1002/lary.28233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。